• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 9 of 100
used tablet blister packs
TechMost of the world’s 35,000 online pharmacies are run illegally and consumers who use them risk getting bad drugs, US report warns
By Elaine Kurtenbach and The Associated PressJanuary 9, 2025
A white sign featuring the Pfizer logo
HealthGSK, Pfizer RSV shots must warn about rare paralysis risk
By BloombergJanuary 8, 2025
Entrepreneur and Cost Plus Drugs cofounder Mark Cuban (right) speaks with Andrew Nusca, editorial director of Fortune’s Brainstorm series, at a Brainstorm Tech dinner on Monday, Jan. 6, 2025, in Las Vegas.
HealthMark Cuban once helped his college friend save almost $10,000 on prescriptions after a ‘horrific car accident’
By Lindsey LeakeJanuary 7, 2025
The 2024–25 seasonal influenza vaccine doesn’t prevent H5N1 bird flu but could play a pivotal role in preventing a pandemic.
HealthBird flu could merge with seasonal flu to make mutated virus that could spread among humans, CDC warns
By Lindsey LeakeJanuary 3, 2025
Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict
HealthElon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict
By Alexa MikhailDecember 27, 2024
Photo of Bill Anderson
SuccessA year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
By Ryan HoggDecember 24, 2024
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
HealthMerck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By Lindsey LeakeDecember 20, 2024
Novo Nordisk advertising flags and logo on facade, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
HealthNovo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
By Ryan Hogg and AFPDecember 20, 2024
Merck snags Chinese obesity drug in nearly $2 billion deal
TechMerck snags Chinese obesity drug in nearly $2 billion deal
By Robert Langreth and BloombergDecember 18, 2024
As you dive into your New Year’s resolutions, taking precautions to protect yourself from a quartet of infectious diseases can lessen your odds of starting off 2025 sick.
HealthPublic health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
By Lindsey LeakeDecember 18, 2024
NXTL 2024. From left to right: Apple's John Ternus, Amazon's Jamil Ghani, Walmart's Latriece Watkins and Megan Crozier, Nike's Craig Williams, and WinField's Leah Anderson.
NewslettersFortune Next to Lead: The 25 Most Powerful Rising Executives in the Fortune 500
By Ruth Umoh and Natalie McCormickDecember 17, 2024
The polio vaccine has all but obliterated the illness that once killed thousands and paralyzed 15,000 people nationwide every year.
HealthPolio is a deadly disease with a vaccine that RFK Jr.’s adviser wants to ban. Here’s how the immunization works
By Lindsey LeakeDecember 13, 2024
Older man sitting at table holding his arm still as he eats soup
HealthHope for Parkinson’s disease symptoms is found in late-stage drug study
By Beth GreenfieldDecember 10, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
HealthZepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
By Lindsey LeakeDecember 4, 2024
Abortion went first. Contraceptives could be next—unless men step up
CommentaryAbortion went first. Contraceptives could be next—unless men step up
By Akash BakshiDecember 4, 2024
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.